Article info

PDF
Concise report
Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials

Authors

  1. Correspondence to Dr Matthieu Roustit, Unité de Pharmacologie Clinique, Centre d'Investigation Clinique de Grenoble—Inserm CIC03, CHU de Grenoble, 38043 Grenoble Cedex 09, France; MRoustit{at}chu-grenoble.fr
View Full Text

Citation

Roustit M, Blaise S, Allanore Y, et al
Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials

Publication history

  • Received October 16, 2012
  • Revised January 9, 2013
  • Accepted February 3, 2013
  • First published February 20, 2013.
Online issue publication 
September 04, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.